0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Next Generation IVD Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-12K18669
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Next Generation IVD Market Research Report 2024
BUY CHAPTERS

Global Next Generation IVD Market Research Report 2024

Code: QYRE-Auto-12K18669
Report
December 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Next Generation IVD Market Size

The global market for Next Generation IVD was valued at US$ 42340 million in the year 2023 and is projected to reach a revised size of US$ 77050 million by 2030, growing at a CAGR of 9.0% during the forecast period.

Next Generation IVD Market

Next Generation IVD Market

Next-Generation In Vitro Diagnostics (IVD) refers to advanced diagnostic tools and technologies designed to enhance the precision, speed, and accessibility of medical testing. These solutions leverage cutting-edge methodologies such as molecular diagnostics, artificial intelligence, microfluidics, and next-generation sequencing (NGS). The goal of next-gen IVDs is to enable earlier detection of diseases, personalized medicine, and better disease management, ultimately improving patient outcomes. Examples include real-time PCR, liquid biopsy platforms, and point-of-care devices that can deliver rapid, actionable results.
North American market for Next Generation IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation IVD in Autoimmune Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation IVD include Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation IVD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation IVD.
The Next Generation IVD market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation IVD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation IVD companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Next Generation IVD Market Report

Report Metric Details
Report Name Next Generation IVD Market
Accounted market size in year US$ 42340 million
Forecasted market size in 2030 US$ 77050 million
CAGR 9.0%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
  • Consumables
  • Instruments
Segment by Application
  • Autoimmune Diseases
  • Cardiology
  • Diabetes
  • Infectious Diseases
  • Nephrology
  • Oncology
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, Hangzhou Yousida, Illumina, Eurofins Scientific, BGI, Natera, Berry Genomics, Novogene, BGI Intelligence, LabCorp, Pacific Biosciences, Azenta Life Sciences, Oxford Nanopore, Macrogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Next Generation IVD company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Next Generation IVD Market growing?

Ans: The Next Generation IVD Market witnessing a CAGR of 9.0% during the forecast period 2024-2030.

What is the Next Generation IVD Market size in 2030?

Ans: The Next Generation IVD Market size in 2030 will be US$ 77050 million.

Who are the main players in the Next Generation IVD Market report?

Ans: The main players in the Next Generation IVD Market are Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, Hangzhou Yousida, Illumina, Eurofins Scientific, BGI, Natera, Berry Genomics, Novogene, BGI Intelligence, LabCorp, Pacific Biosciences, Azenta Life Sciences, Oxford Nanopore, Macrogen

What are the Application segmentation covered in the Next Generation IVD Market report?

Ans: The Applications covered in the Next Generation IVD Market report are Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Oncology

What are the Type segmentation covered in the Next Generation IVD Market report?

Ans: The Types covered in the Next Generation IVD Market report are Consumables, Instruments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation IVD Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Next Generation IVD Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Autoimmune Diseases
1.3.3 Cardiology
1.3.4 Diabetes
1.3.5 Infectious Diseases
1.3.6 Nephrology
1.3.7 Oncology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation IVD Market Perspective (2019-2030)
2.2 Global Next Generation IVD Growth Trends by Region
2.2.1 Global Next Generation IVD Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation IVD Historic Market Size by Region (2019-2024)
2.2.3 Next Generation IVD Forecasted Market Size by Region (2025-2030)
2.3 Next Generation IVD Market Dynamics
2.3.1 Next Generation IVD Industry Trends
2.3.2 Next Generation IVD Market Drivers
2.3.3 Next Generation IVD Market Challenges
2.3.4 Next Generation IVD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation IVD Players by Revenue
3.1.1 Global Top Next Generation IVD Players by Revenue (2019-2024)
3.1.2 Global Next Generation IVD Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation IVD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Next Generation IVD Revenue
3.4 Global Next Generation IVD Market Concentration Ratio
3.4.1 Global Next Generation IVD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation IVD Revenue in 2023
3.5 Global Key Players of Next Generation IVD Head office and Area Served
3.6 Global Key Players of Next Generation IVD, Product and Application
3.7 Global Key Players of Next Generation IVD, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation IVD Breakdown Data by Type
4.1 Global Next Generation IVD Historic Market Size by Type (2019-2024)
4.2 Global Next Generation IVD Forecasted Market Size by Type (2025-2030)
5 Next Generation IVD Breakdown Data by Application
5.1 Global Next Generation IVD Historic Market Size by Application (2019-2024)
5.2 Global Next Generation IVD Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation IVD Market Size (2019-2030)
6.2 North America Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation IVD Market Size by Country (2019-2024)
6.4 North America Next Generation IVD Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation IVD Market Size (2019-2030)
7.2 Europe Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation IVD Market Size by Country (2019-2024)
7.4 Europe Next Generation IVD Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation IVD Market Size (2019-2030)
8.2 Asia-Pacific Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation IVD Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation IVD Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation IVD Market Size (2019-2030)
9.2 Latin America Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation IVD Market Size by Country (2019-2024)
9.4 Latin America Next Generation IVD Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation IVD Market Size (2019-2030)
10.2 Middle East & Africa Next Generation IVD Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation IVD Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation IVD Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Next Generation IVD Introduction
11.1.4 Danaher Revenue in Next Generation IVD Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Next Generation IVD Introduction
11.2.4 Roche Revenue in Next Generation IVD Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Next Generation IVD Introduction
11.3.4 Abbott Revenue in Next Generation IVD Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Next Generation IVD Introduction
11.4.4 bioMérieux Revenue in Next Generation IVD Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Next Generation IVD Introduction
11.5.4 Hologic Revenue in Next Generation IVD Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Next Generation IVD Introduction
11.6.4 Thermo Fisher Scientific Revenue in Next Generation IVD Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bio-Bio
11.7.1 Bio-Bio Company Details
11.7.2 Bio-Bio Business Overview
11.7.3 Bio-Bio Next Generation IVD Introduction
11.7.4 Bio-Bio Revenue in Next Generation IVD Business (2019-2024)
11.7.5 Bio-Bio Recent Development
11.8 B
11.8.1 B Company Details
11.8.2 B Business Overview
11.8.3 B Next Generation IVD Introduction
11.8.4 B Revenue in Next Generation IVD Business (2019-2024)
11.8.5 B Recent Development
11.9 Shengxiang Bio
11.9.1 Shengxiang Bio Company Details
11.9.2 Shengxiang Bio Business Overview
11.9.3 Shengxiang Bio Next Generation IVD Introduction
11.9.4 Shengxiang Bio Revenue in Next Generation IVD Business (2019-2024)
11.9.5 Shengxiang Bio Recent Development
11.10 COYOTE
11.10.1 COYOTE Company Details
11.10.2 COYOTE Business Overview
11.10.3 COYOTE Next Generation IVD Introduction
11.10.4 COYOTE Revenue in Next Generation IVD Business (2019-2024)
11.10.5 COYOTE Recent Development
11.11 Hangzhou Yousida
11.11.1 Hangzhou Yousida Company Details
11.11.2 Hangzhou Yousida Business Overview
11.11.3 Hangzhou Yousida Next Generation IVD Introduction
11.11.4 Hangzhou Yousida Revenue in Next Generation IVD Business (2019-2024)
11.11.5 Hangzhou Yousida Recent Development
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Next Generation IVD Introduction
11.12.4 Illumina Revenue in Next Generation IVD Business (2019-2024)
11.12.5 Illumina Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Details
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Next Generation IVD Introduction
11.13.4 Eurofins Scientific Revenue in Next Generation IVD Business (2019-2024)
11.13.5 Eurofins Scientific Recent Development
11.14 BGI
11.14.1 BGI Company Details
11.14.2 BGI Business Overview
11.14.3 BGI Next Generation IVD Introduction
11.14.4 BGI Revenue in Next Generation IVD Business (2019-2024)
11.14.5 BGI Recent Development
11.15 Natera
11.15.1 Natera Company Details
11.15.2 Natera Business Overview
11.15.3 Natera Next Generation IVD Introduction
11.15.4 Natera Revenue in Next Generation IVD Business (2019-2024)
11.15.5 Natera Recent Development
11.16 Berry Genomics
11.16.1 Berry Genomics Company Details
11.16.2 Berry Genomics Business Overview
11.16.3 Berry Genomics Next Generation IVD Introduction
11.16.4 Berry Genomics Revenue in Next Generation IVD Business (2019-2024)
11.16.5 Berry Genomics Recent Development
11.17 Novogene
11.17.1 Novogene Company Details
11.17.2 Novogene Business Overview
11.17.3 Novogene Next Generation IVD Introduction
11.17.4 Novogene Revenue in Next Generation IVD Business (2019-2024)
11.17.5 Novogene Recent Development
11.18 BGI Intelligence
11.18.1 BGI Intelligence Company Details
11.18.2 BGI Intelligence Business Overview
11.18.3 BGI Intelligence Next Generation IVD Introduction
11.18.4 BGI Intelligence Revenue in Next Generation IVD Business (2019-2024)
11.18.5 BGI Intelligence Recent Development
11.19 LabCorp
11.19.1 LabCorp Company Details
11.19.2 LabCorp Business Overview
11.19.3 LabCorp Next Generation IVD Introduction
11.19.4 LabCorp Revenue in Next Generation IVD Business (2019-2024)
11.19.5 LabCorp Recent Development
11.20 Pacific Biosciences
11.20.1 Pacific Biosciences Company Details
11.20.2 Pacific Biosciences Business Overview
11.20.3 Pacific Biosciences Next Generation IVD Introduction
11.20.4 Pacific Biosciences Revenue in Next Generation IVD Business (2019-2024)
11.20.5 Pacific Biosciences Recent Development
11.21 Azenta Life Sciences
11.21.1 Azenta Life Sciences Company Details
11.21.2 Azenta Life Sciences Business Overview
11.21.3 Azenta Life Sciences Next Generation IVD Introduction
11.21.4 Azenta Life Sciences Revenue in Next Generation IVD Business (2019-2024)
11.21.5 Azenta Life Sciences Recent Development
11.22 Oxford Nanopore
11.22.1 Oxford Nanopore Company Details
11.22.2 Oxford Nanopore Business Overview
11.22.3 Oxford Nanopore Next Generation IVD Introduction
11.22.4 Oxford Nanopore Revenue in Next Generation IVD Business (2019-2024)
11.22.5 Oxford Nanopore Recent Development
11.23 Macrogen
11.23.1 Macrogen Company Details
11.23.2 Macrogen Business Overview
11.23.3 Macrogen Next Generation IVD Introduction
11.23.4 Macrogen Revenue in Next Generation IVD Business (2019-2024)
11.23.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Next Generation IVD Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Consumables
 Table 3. Key Players of Instruments
 Table 4. Global Next Generation IVD Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Next Generation IVD Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Next Generation IVD Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Next Generation IVD Market Share by Region (2019-2024)
 Table 8. Global Next Generation IVD Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Next Generation IVD Market Share by Region (2025-2030)
 Table 10. Next Generation IVD Market Trends
 Table 11. Next Generation IVD Market Drivers
 Table 12. Next Generation IVD Market Challenges
 Table 13. Next Generation IVD Market Restraints
 Table 14. Global Next Generation IVD Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Next Generation IVD Market Share by Players (2019-2024)
 Table 16. Global Top Next Generation IVD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation IVD as of 2023)
 Table 17. Ranking of Global Top Next Generation IVD Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Next Generation IVD Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Next Generation IVD, Headquarters and Area Served
 Table 20. Global Key Players of Next Generation IVD, Product and Application
 Table 21. Global Key Players of Next Generation IVD, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Next Generation IVD Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Next Generation IVD Revenue Market Share by Type (2019-2024)
 Table 25. Global Next Generation IVD Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Next Generation IVD Revenue Market Share by Type (2025-2030)
 Table 27. Global Next Generation IVD Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Next Generation IVD Revenue Market Share by Application (2019-2024)
 Table 29. Global Next Generation IVD Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Next Generation IVD Revenue Market Share by Application (2025-2030)
 Table 31. North America Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Next Generation IVD Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Next Generation IVD Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Next Generation IVD Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Next Generation IVD Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Next Generation IVD Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Next Generation IVD Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Next Generation IVD Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Next Generation IVD Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Next Generation IVD Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Next Generation IVD Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Danaher Company Details
 Table 47. Danaher Business Overview
 Table 48. Danaher Next Generation IVD Product
 Table 49. Danaher Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 50. Danaher Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Next Generation IVD Product
 Table 54. Roche Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Abbott Company Details
 Table 57. Abbott Business Overview
 Table 58. Abbott Next Generation IVD Product
 Table 59. Abbott Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 60. Abbott Recent Development
 Table 61. bioMérieux Company Details
 Table 62. bioMérieux Business Overview
 Table 63. bioMérieux Next Generation IVD Product
 Table 64. bioMérieux Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 65. bioMérieux Recent Development
 Table 66. Hologic Company Details
 Table 67. Hologic Business Overview
 Table 68. Hologic Next Generation IVD Product
 Table 69. Hologic Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 70. Hologic Recent Development
 Table 71. Thermo Fisher Scientific Company Details
 Table 72. Thermo Fisher Scientific Business Overview
 Table 73. Thermo Fisher Scientific Next Generation IVD Product
 Table 74. Thermo Fisher Scientific Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 75. Thermo Fisher Scientific Recent Development
 Table 76. Bio-Bio Company Details
 Table 77. Bio-Bio Business Overview
 Table 78. Bio-Bio Next Generation IVD Product
 Table 79. Bio-Bio Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 80. Bio-Bio Recent Development
 Table 81. B Company Details
 Table 82. B Business Overview
 Table 83. B Next Generation IVD Product
 Table 84. B Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 85. B Recent Development
 Table 86. Shengxiang Bio Company Details
 Table 87. Shengxiang Bio Business Overview
 Table 88. Shengxiang Bio Next Generation IVD Product
 Table 89. Shengxiang Bio Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 90. Shengxiang Bio Recent Development
 Table 91. COYOTE Company Details
 Table 92. COYOTE Business Overview
 Table 93. COYOTE Next Generation IVD Product
 Table 94. COYOTE Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 95. COYOTE Recent Development
 Table 96. Hangzhou Yousida Company Details
 Table 97. Hangzhou Yousida Business Overview
 Table 98. Hangzhou Yousida Next Generation IVD Product
 Table 99. Hangzhou Yousida Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 100. Hangzhou Yousida Recent Development
 Table 101. Illumina Company Details
 Table 102. Illumina Business Overview
 Table 103. Illumina Next Generation IVD Product
 Table 104. Illumina Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 105. Illumina Recent Development
 Table 106. Eurofins Scientific Company Details
 Table 107. Eurofins Scientific Business Overview
 Table 108. Eurofins Scientific Next Generation IVD Product
 Table 109. Eurofins Scientific Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 110. Eurofins Scientific Recent Development
 Table 111. BGI Company Details
 Table 112. BGI Business Overview
 Table 113. BGI Next Generation IVD Product
 Table 114. BGI Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 115. BGI Recent Development
 Table 116. Natera Company Details
 Table 117. Natera Business Overview
 Table 118. Natera Next Generation IVD Product
 Table 119. Natera Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 120. Natera Recent Development
 Table 121. Berry Genomics Company Details
 Table 122. Berry Genomics Business Overview
 Table 123. Berry Genomics Next Generation IVD Product
 Table 124. Berry Genomics Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 125. Berry Genomics Recent Development
 Table 126. Novogene Company Details
 Table 127. Novogene Business Overview
 Table 128. Novogene Next Generation IVD Product
 Table 129. Novogene Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 130. Novogene Recent Development
 Table 131. BGI Intelligence Company Details
 Table 132. BGI Intelligence Business Overview
 Table 133. BGI Intelligence Next Generation IVD Product
 Table 134. BGI Intelligence Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 135. BGI Intelligence Recent Development
 Table 136. LabCorp Company Details
 Table 137. LabCorp Business Overview
 Table 138. LabCorp Next Generation IVD Product
 Table 139. LabCorp Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 140. LabCorp Recent Development
 Table 141. Pacific Biosciences Company Details
 Table 142. Pacific Biosciences Business Overview
 Table 143. Pacific Biosciences Next Generation IVD Product
 Table 144. Pacific Biosciences Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 145. Pacific Biosciences Recent Development
 Table 146. Azenta Life Sciences Company Details
 Table 147. Azenta Life Sciences Business Overview
 Table 148. Azenta Life Sciences Next Generation IVD Product
 Table 149. Azenta Life Sciences Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 150. Azenta Life Sciences Recent Development
 Table 151. Oxford Nanopore Company Details
 Table 152. Oxford Nanopore Business Overview
 Table 153. Oxford Nanopore Next Generation IVD Product
 Table 154. Oxford Nanopore Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 155. Oxford Nanopore Recent Development
 Table 156. Macrogen Company Details
 Table 157. Macrogen Business Overview
 Table 158. Macrogen Next Generation IVD Product
 Table 159. Macrogen Revenue in Next Generation IVD Business (2019-2024) & (US$ Million)
 Table 160. Macrogen Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Next Generation IVD Picture
 Figure 2. Global Next Generation IVD Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Next Generation IVD Market Share by Type: 2023 VS 2030
 Figure 4. Consumables Features
 Figure 5. Instruments Features
 Figure 6. Global Next Generation IVD Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Next Generation IVD Market Share by Application: 2023 VS 2030
 Figure 8. Autoimmune Diseases Case Studies
 Figure 9. Cardiology Case Studies
 Figure 10. Diabetes Case Studies
 Figure 11. Infectious Diseases Case Studies
 Figure 12. Nephrology Case Studies
 Figure 13. Oncology Case Studies
 Figure 14. Next Generation IVD Report Years Considered
 Figure 15. Global Next Generation IVD Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global Next Generation IVD Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Next Generation IVD Market Share by Region: 2023 VS 2030
 Figure 18. Global Next Generation IVD Market Share by Players in 2023
 Figure 19. Global Top Next Generation IVD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation IVD as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by Next Generation IVD Revenue in 2023
 Figure 21. North America Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America Next Generation IVD Market Share by Country (2019-2030)
 Figure 23. United States Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Next Generation IVD Market Share by Country (2019-2030)
 Figure 27. Germany Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Next Generation IVD Market Share by Region (2019-2030)
 Figure 35. China Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Japan Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. South Korea Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Southeast Asia Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. India Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Australia Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Next Generation IVD Market Share by Country (2019-2030)
 Figure 43. Mexico Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Brazil Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Next Generation IVD Market Share by Country (2019-2030)
 Figure 47. Turkey Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. UAE Next Generation IVD Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Danaher Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 51. Roche Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 52. Abbott Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 53. bioMérieux Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 54. Hologic Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 56. Bio-Bio Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 57. B Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 58. Shengxiang Bio Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 59. COYOTE Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 60. Hangzhou Yousida Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 61. Illumina Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 62. Eurofins Scientific Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 63. BGI Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 64. Natera Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 65. Berry Genomics Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 66. Novogene Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 67. BGI Intelligence Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 68. LabCorp Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 69. Pacific Biosciences Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 70. Azenta Life Sciences Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 71. Oxford Nanopore Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 72. Macrogen Revenue Growth Rate in Next Generation IVD Business (2019-2024)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS